Interim Analysis Symposium Philadelphia, Pennsylvania, USA 27-28 March 2017

Description:
ExL Events’ inaugural Interim Analysis Symposium is the first advanced conference on interim analysis that provides experts with a platform to exchange best practices and share lessons learned with their peers, thought leaders, stakeholders and regulators across the scope of clinical trials.

The mission of the Interim Analysis Symposium is to provide attendees with proven processes and strategies that enable them to monitor the collection of interim data more efficiently and to better assess the outcomes of clinical trials. Over the course of two days, you will have the opportunity to consult with and learn from industry experts during in-depth sessions, case studies, an interactive panel and networking breaks.

Prices:
EARLY BIRD PRICING - Register by Friday, February 10, 2017: USD 1895
STANDARD PRICING - Register after February 10, 2017: USD 2095
ONSITE PRICING: USD 2195

Speakers: Vice President Clinical Research, Drug Safety and Medical Affairs, Director, Collaborative Studies Coordinating Center, Department of Biostatistics, Director, Biostatistics, Vice President and Scientific Fellow, Head of ACT CoE, Senior Vice President, Biometrics and Regulatory Affairs, Vice President, Translational Medicine, Biomarkers and Diagnostics, Professor, Biostatistics, Vice President, Biostatistics and Head of Research and Consulting Center, Associate Director, Clinical Data Management, Cardio and Infectious Disease, Senior Director, Biostatistics TA Head for Respiratory, Etc.